The chemical class of Swsap1 inhibitors comprises a diverse range of compounds, most of which are small molecule inhibitors that target various signaling pathways and enzymes within cells. These compounds are not specific to Swsap1 but can indirectly influence its function by modulating the activity of related pathways. For instance, inhibitors of the PI3K/Akt/mTOR pathway, such as Wortmannin and LY294002, can alter cell survival and proliferation signals that may intersect with Swsap1's role in cellular processes. Rapamycin, an mTOR inhibitor, and Triciribine, an Akt inhibitor, also belong to this category and can affect the same network of signals.
Moreover, the MAPK pathway, which is crucial for cell differentiation, proliferation, and survival, can be influenced by chemicals like U0126, a MEK inhibitor, and SP600125, a JNK inhibitor. By altering the MAPK pathway, these compounds indirectly impact the cellular context within which Swsap1 operates. Additionally, tyrosine kinase inhibitors such as Dasatinib and Imatinib can modify cell signaling in a way that affects the processes Swsap1 is associated with. Palbociclib, a CDK4/6 inhibitor, can influence the cell cycle, potentially altering the cellular environment and function where Swsap1 is active.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which is part of signaling pathways that can intersect with those involving Swsap1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, affecting pathways that Swsap1 may be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, indirectly affecting cellular processes that Swsap1 could influence. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Akt inhibitor, possibly impacting downstream effects of Swsap1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, indirectly affecting pathways that could intersect with Swsap1 function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially altering signaling cascades involving Swsap1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, influencing stress response pathways connected to Swsap1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which could intersect with Swsap1-related signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family tyrosine kinase inhibitor, potentially affecting Swsap1 interactions. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Bcr-Abl tyrosine kinase inhibitor, influencing cell signaling pathways where Swsap1 may play a role. | ||||||